Spotlight Asset Group, Inc.
- SEC CIK
- 0001809159
- Latest filing
- Jul 24, 2024
RLMD holding history
Relmada Therapeutics, Inc. in every 13F filed by Spotlight Asset Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RLMD overviewAll 13F holders of RLMDFull Q2 2024 holdings
- Shares (Q2 2024)
- 20,000
- Value
- $60.0K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 20,000 | $60.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 20,000 | $93.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 20,000 | $60.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 20,000 | $60.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 20,000 | $49.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 20,000 | $140.0K | 0.1% | – | No prior filing | Holders |
| Q4 2022 | – | – | – | – | Not filed | Holders |
| Q3 2022 | 20,000 | $140.0K | 0.1% | – | No prior filing | Holders |
| Q4 2021 | – | – | – | – | Not filed | Holders |
| Q3 2021 | 30,265 | $793.0K | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2021 | 30,265 | $969.0K | 0.4% | +5,700+23.2% | Added | Holders |
| Q1 2021 | 24,565 | $865.0K | 0.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.